Literature DB >> 10694213

Involvement of cyclic AMP - PKA pathway in VIP-induced, charybdotoxin-sensitive relaxation of longitudinal muscle of the distal colon of Wistar-ST rats.

M Kishi1, T Takeuchi, H Katayama, Y Yamazaki, H Nishio, F Hata, T Takewaki.   

Abstract

The intracellular mechanism of vasoactive intestinal peptide (VIP)-induced, charybdotoxin (ChTx)-sensitive relaxation of longitudinal muscle of the distal colon of Wistar-ST rats was studied. A single pulse or 100 pulses at 10 Hz of electrical field stimulation (EFS) induced rapid transient relaxation or that with a subsequent contraction of the longitudinal muscle in the presence of atropine and guanethidine, respectively. Rp-8 bromo cAMPS, an inhibitor of cyclic AMP dependent protein kinase (PKA), at 30 microM inhibited the relaxations induced by EFS with a single or 100 pulses maximally by about 80 or 60%, respectively. It also inhibited VIP (300 nM)-induced relaxation by 82%. VIP (100 nM - 1 microM) increased the cyclic AMP content of longitudinal muscle myenteric plexus preparations obtained from the distal colon. ChTx at 100 nM almost completely inhibited 8 bromo cyclic AMP-induced relaxation of the distal segments. EFS with two or three pulses at 10 Hz induced inhibitory junction potentials consisting of two phases, rapid and subsequent slow hyperpolarization in the membrane potential of longitudinal smooth muscle cells. Rp-cAMPS, another inhibitor of PKA, inhibited the delayed slow hyperpolarization. It also inhibited the exogenously added VIP-induced hyperpolarization of the cell membrane. Thus, the present study suggests that activation of PKA via activation of VIP receptors is associated with activation of ChTx-sensitive K(+) channels in relaxation of longitudinal muscle of the distal colon of Wistar-ST rats. British Journal of Pharmacology (2000) 129, 140 - 146

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694213      PMCID: PMC1621121          DOI: 10.1038/sj.bjp.0702998

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Vasoactive intestinal polypeptide as possible mediator of relaxation in the rat gastric fundus.

Authors:  F A De Beurme; R A Lefebvre
Journal:  J Pharm Pharmacol       Date:  1988-10       Impact factor: 3.765

Review 2.  The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

3.  Evidence against VIP as the inhibitory transmitter in non-adrenergic, non-cholinergic nerves supplying the longitudinal muscle of the mouse colon.

Authors:  J Fontaine; A R Grivegnee; P Robberecht
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

4.  Relaxation of isolated gastric smooth muscle cells by vasoactive intestinal peptide.

Authors:  K N Bitar; G M Makhlouf
Journal:  Science       Date:  1982-04-30       Impact factor: 47.728

5.  Lower esophageal sphincter relaxation is associated with increased cyclic nucleotide content.

Authors:  T J Torphy; C F Fine; M Burman; M S Barnette; H S Ormsbee
Journal:  Am J Physiol       Date:  1986-12

6.  Colonic peristaltic reflex: identification of vasoactive intestinal peptide as mediator of descending relaxation.

Authors:  J R Grider; G M Makhlouf
Journal:  Am J Physiol       Date:  1986-07

7.  Vasoactive intestinal peptide. Relaxant neurotransmitter in tenia coli of the guinea pig.

Authors:  J R Grider; M B Cable; K N Bitar; S I Said; G M Makhlouf
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

8.  Vasoactive intestinal polypeptide: a putative transmitter in the canine gastric muscularis mucosa.

Authors:  F Angel; V L Go; P F Schmalz; J H Szurszewski
Journal:  J Physiol       Date:  1983-08       Impact factor: 5.182

9.  Similarities between the relaxations induced by vasoactive intestinal peptide and by stimulation of the non-adrenergic non-cholinergic neurons in the rat stomach.

Authors:  K Kamata; A Sakamoto; Y Kasuya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

10.  Vasoactive intestinal peptide as a neural mediator of gastric relaxation.

Authors:  J R Grider; M B Cable; S I Said; G M Makhlouf
Journal:  Am J Physiol       Date:  1985-01
View more
  6 in total

1.  Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.

Authors:  Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz
Journal:  J Physiol       Date:  2012-03-25       Impact factor: 5.182

2.  Roles of PACAP and PHI as inhibitory neurotransmitters in the circular muscle of mouse antrum.

Authors:  Makiko Toyoshima; Tadayoshi Takeuchi; Hiroto Goto; Kazunori Mukai; Norihito Shintani; Hitoshi Hashimoto; Akemichi Baba; Fumiaki Hata
Journal:  Pflugers Arch       Date:  2005-11-15       Impact factor: 3.657

3.  Increase in participation of vasoactive intestinal peptide in relaxation of the distal colon of Wistar rats with age.

Authors:  T Takeuchi; T Negoro; M Yamaji; Y Yamazaki; A Fujita; H Nishio; T Takewaki; K Takatsuji; F Hata
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

4.  A possible role of neurotensin in NANC relaxation of longitudinal muscle of the jejunum and ileum of Wistar rats.

Authors:  Michiru Yamaji; Mayuko Ohta; Yasuko Yamazaki; Kaori Fujinami; Akikazu Fujita; Tadayoshi Takeuchi; Fumiaki Hata; Tadashi Takewaki
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

5.  Characterization of the non-nitrergic NANC relaxation responses in the rabbit vaginal wall.

Authors:  Tom Ziessen; Salvador Moncada; Selim Cellek
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

6.  Bioengineered three-dimensional physiological model of colonic longitudinal smooth muscle in vitro.

Authors:  Shreya Raghavan; Mai T Lam; Lesley L Foster; Robert R Gilmont; Sita Somara; Shuichi Takayama; Khalil N Bitar
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.